Literature DB >> 15022187

Parkinson's prevalence estimated by a state registry.

Daniel Strickland1, John M Bertoni.   

Abstract

A solid understanding of the descriptive epidemiology of a disease is essential in etiologic investigations; this includes prevalence and incidence, as well as groups within the larger community who may have noticeably lower or higher rates. We ascertained the usefulness of a non-traditional registry in describing Parkinson's disease (PD) patterns in a community. A passive surveillance PD registry in Nebraska began data collection on 1 January 1997. All physicians were required to report PD diagnosis, pharmacists reported new prescriptions of anti-PD drugs (PD cases were confirmed later with the prescribing physician), and there was a patient self-report mechanism. The overlap of reporting by the sources allowed estimation of the number not reported by any source, using the statistical technique "capture-recapture." As of January 2000, the Nebraska PD Registry had reports of 5,062 PD patients. The number not reported by any Registry reporting source was calculated to be 117, leading to an estimated total of 5,179 cases and a prevalence of 329.3 per 100,000 population. Tabulations of age- and gender-specific prevalence rates, as well as county-level estimates, allow examination of areas of elevated or lowered prevalence. The combination of a passive surveillance system and capture-recapture technique presents a useful method for epidemiologic description, and more traditional survey methods could benefit by including capture-recapture capability. Copyright 2003 Movement Disorder Society

Entities:  

Mesh:

Year:  2004        PMID: 15022187     DOI: 10.1002/mds.10619

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  25 in total

Review 1.  Alternatives to levodopa in the initial treatment of early Parkinson's disease.

Authors:  Andrew Lees
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

2.  Risk of sleep-disordered breathing in Parkinson's disease.

Authors:  Wattanachai Chotinaiwattarakul; Praveen Dayalu; Ronald D Chervin; Roger L Albin
Journal:  Sleep Breath       Date:  2010-05-16       Impact factor: 2.816

3.  Projection of the prevalence of Parkinson's disease in the coming decades: Revisited.

Authors:  Alexander Rossi; Kristin Berger; Honglei Chen; Douglas Leslie; Richard B Mailman; Xuemei Huang
Journal:  Mov Disord       Date:  2017-06-07       Impact factor: 10.338

4.  Associations and implications of low health literacy in Parkinson's Disease.

Authors:  Jori E Fleisher; Krunal Shah; Whitney Fitts; Nabila A Dahodwala
Journal:  Mov Disord Clin Pract       Date:  2015-12-14

5.  Admixing of MPTP-Resistant and Susceptible Mice Strains Augments Nigrostriatal Neuronal Correlates to Resist MPTP-Induced Neurodegeneration.

Authors:  D J Vidyadhara; H Yarreiphang; T R Raju; Phalguni Anand Alladi
Journal:  Mol Neurobiol       Date:  2016-10-04       Impact factor: 5.590

6.  Podokinetic after-rotation in Parkinson disease.

Authors:  Minna Hong; Joel S Perlmutter; Gammon M Earhart
Journal:  Brain Res       Date:  2006-11-30       Impact factor: 3.252

7.  Fasudil Enhances Therapeutic Efficacy of Neural Stem Cells in the Mouse Model of MPTP-Induced Parkinson's Disease.

Authors:  Yan-Hua Li; Jing-Wen Yu; Jian-Yin Xi; Wen-Bo Yu; Jian-Chun Liu; Qing Wang; Li-Juan Song; Ling Feng; Ya-Ping Yan; Guang-Xian Zhang; Bao-Guo Xiao; Cun-Gen Ma
Journal:  Mol Neurobiol       Date:  2016-09-02       Impact factor: 5.590

8.  Measures of anxiety, sensorimotor function, and memory in male and female mGluR4⁻/⁻ mice.

Authors:  Matthew J Davis; Tammie Haley; Robert M Duvoisin; Jacob Raber
Journal:  Behav Brain Res       Date:  2012-01-02       Impact factor: 3.332

Review 9.  Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's disease.

Authors:  Georgia S Gaki; Athanasios G Papavassiliou
Journal:  Neuromolecular Med       Date:  2014-02-13       Impact factor: 3.843

10.  Medicare capitation model, functional status, and multiple comorbidities: model accuracy.

Authors:  Katia Noyes; Hangsheng Liu; Helena Temkin-Greener
Journal:  Am J Manag Care       Date:  2008-10       Impact factor: 2.229

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.